Dexamethasone Treatment Options in United Kingdom

A collection of 187 research studies where Dexamethasone is the interventional treatment. These studies are located in the United Kingdom . Dexamethasone is used for conditions such as Multiple Myeloma, Postoperative Pain and Lymphoma.

Home

United Kingdom

All Treatments

Dexamethasone

Show Filters

Match to Clinical Trials

Access to cutting-edge treatments

Latest clinical trials

Find trials in your area

Start Matching

Filter by Age

Open-label, Phase II, Study of Everolimus Plus Letrozole in Postmenopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer

NCT01698918

Completed

The purpose of this study was to assess the efficacy and safety of first-line treatment with everolimus plus letrozole in postmenopausal women with estrogen receptor-positive (ER+), human epidermal growth factor receptor 2 negative (HER2-) locally advanced or metastatic breast cancer. Moreover, the study also aimed to investigate the efficacy and safety of second line treatment with everolumus plus examestane in participants whose disease progressed during everolimus plus letrozole therapy.

Gender:

FEMALE

Ages:

18 years and above

Trial Updated:

04/28/2023

Locations: University of Alabama Comprehensive Cancer Center SC-2, Birmingham, Alabama +51 locations

University of Alabama Comprehensive Cancer Center SC-2, Birmingham, Alabama

Banner MD Anderson Cancer Center, Gilbert, Arizona

Loma Linda University Loma Linda, Loma Linda, California

Breastlink Medical Group Dept. of BreastlinkResearchGrp, Long Beach, California

Oncology Specialists, SC Advocate Medical Group-Niles, Park Ridge, Illinois

St. Francis Health Comprehensive Cancer Center, Topeka, Kansas

Norton Healthcare Inc SC, Louisville, Kentucky

Baystate Medical Center SC-2, Springfield, Massachusetts

Saint Barnabas Medical Center CancerCenter of Saint Barnabas, Livingston, New Jersey

University of New Mexico Hospital SC, Albuquerque, New Mexico

Broome Oncology SC, Johnson City, New York

Columbia University Medical Center- New York Presbyterian Columbia, New York, New York

Cone Health Cancer Center, Greensboro, North Carolina

East Texas Hematology Clinic SC, Lufkin, Texas

Utah Cancer Specialists Dept.of Utah Cancer Spec. (3), Salt Lake City, Utah

Novartis Investigative Site, Santa Rosa, La Pampa

Novartis Investigative Site, Rosario, Santa Fe

Novartis Investigative Site, Porto Alegre, RS

Novartis Investigative Site, Sao Paulo, SP

Novartis Investigative Site, Besancon cedex, Not set

Novartis Investigative Site, Bordeaux, Not set

Novartis Investigative Site, Hyères, Not set

Novartis Investigative Site, Le Chesnay, Not set

Novartis Investigative Site, Lyon, Not set

Novartis Investigative Site, Nancy, Not set

Novartis Investigative Site, Nantes Cedex, Not set

Novartis Investigative Site, Kecskemet, Bacs Kiskun

Novartis Investigative Site, Gyula, Not set

Novartis Investigative Site, Szekszard, Not set

Novartis Investigative Site, Nagoya-city, Aichi

Novartis Investigative Site, Sapporo-city, Hokkaido

Novartis Investigative Site, Shiwa-gun, Iwate

Novartis Investigative Site, Kawasaki-city, Kanagawa

Novartis Investigative Site, Kumamoto City, Kumamoto

Novartis Investigative Site, Seoul, Not set

Novartis Investigative Site, Maastricht, AZ

Novartis Investigative Site, Lisboa, Not set

Novartis Investigative Site, Porto, Not set

Novartis Investigative Site, Salamanca, Castilla Y Leon

Novartis Investigative Site, Valencia, Comunidad Valenciana

Novartis Investigative Site, La Coruna, Galicia

Novartis Investigative Site, Bangkok, Not set

Novartis Investigative Site, Antalya, Not set

Novartis Investigative Site, Istanbul, Not set

Novartis Investigative Site, Izmir, Not set

Novartis Investigative Site, Bath, Not set

Conditions: Hormone Receptor Positive Breast Cancer

Learn More ›

A Study to Determine the Safety and Efficacy for the Combination of Durvalumab and Daratumumab in Relapsed and Refractory Multiple Myeloma

NCT02807454

Terminated

This is an open-label, multicenter study to confirm the safety and efficacy of durvalumab + daratumumab (D2) in subjects with relapsed and refractory multiple myeloma. This study will also explore the safety and efficacy of the addition of pomalidomide + dexamethasone to durvalumab + daratumumab (PD3). On 05 Sep 2017, a Partial Clinical Hold was placed on this study by the United States (US) Food and Drug Administration (FDA). The decision by the FDA was based on data related to risks of anti-p... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

02/16/2023

Locations: City of Hope National Medical Center, Duarte, California +63 locations

City of Hope National Medical Center, Duarte, California

UCLA Division of Hematology Oncology, Los Angeles, California

Colorado Blood Cancer Institute, Denver, Colorado

Local Institution - 007, Denver, Colorado

Emory University Hospital, Atlanta, Georgia

University of Chicago Medical Center, Chicago, Illinois

Center For Cancer and Blood Disorders, Bethesda, Maryland

Dana-Farber Partners Cancer Care, Inc., Boston, Massachusetts

Washington University, Saint Louis, Missouri

Hackensack University Medical Center, Hackensack, New Jersey

Perelman Center for Advanced Medicine, Philadelphia, Pennsylvania

University of Pennsylvania - Perelman Center for Advanced Medicine, Philadelphia, Pennsylvania

Sarah Cannon Research Institute, Nashville, Tennessee

Tennessee Oncology Nashville Drug Development Unit, Nashville, Tennessee

Swedish Medical Center, Seattle, Washington

AZ St-Jan Brugge Oostende AV, Brugge, Not set

Universitaire Ziekenhuizen Leuven Univeristy Hospitals Leuven, Leuven, Not set

Cliniques Universitaires UCL de Mont-Godine, Yvoir, Not set

Local Institution - 103, Saint John, New Brunswick

Saint John Regional Hospital, Saint John, New Brunswick

Local Institution - 104, Toronto, Ontario

Princess Margaret Cancer Centre, Toronto, Ontario

Hopital Maisonneuve-Rosemont, Montreal, Quebec

Local Institution - 101, Montreal, Quebec

MUHC Glen Site, Montreal, Quebec

Local Institution - 552, Copenhagen, Not set

Rigshospitalet University Hospital, Copenhagen, Not set

Local Institution - 553, Odense, Not set

Odense University Hospital, Odense, Not set

Local Institution - 551, Vejle, Not set

Vejle Hospital, Vejle, Not set

Universitatsklinikum Carl Gustav Carus an der TU Dresden, Dresden, Not set

Local Institution - 203, Heidelberg, Not set

Universitatsklinikum Heidelberg, Heidelberg, Not set

University Hospital Tubingen, Tubingen, Not set

Local Institution - 201, Wuerzburg, Not set

Universitatsklinikum Wuerzburg, Wuerzburg, Not set

Local Institution - 354, Bologna, Not set

Policlinico S. Orsola - Malpighi, Bologna, Not set

A.O.U. Maggiore della Carità, Novara, Not set

Local Institution - 353, Novara, Not set

Azienda Ospedaliera di Padova, Padova, Not set

Local Institution - 355, Padova, Not set

Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello, Palermo, Not set

A.O. Universitaria Ospedale S.Chiara Dip.Oncologia, Div. Ematologia, Pisa, Not set

Hospital Durán i Reynals - Instituto Catalàn de Oncologìa ICO, Barcelona, Not set

Local Institution - 453, Barcelona, Not set

Hospital de Cabuenes, Gijon, Not set

Local Institution - 451, Gijon, Not set

Hospital Universitario Fundacion Jimenez Diaz, Madrid, Not set

Local Institution - 452, Madrid, Not set

Hospital 12 de Octubre, Madrid, Not set

Sahlgrenska University Hospital, Gothenburg, Not set

Local Institution - 501, Lund, Not set

Skanes Universitetssjukhus Malmo, Lund, Not set

Local Institution - 502, Stockholm, Not set

Karolinska Universitetssjukhuset - Huddinge, Stockholm, Not set

St. Bartholomew's and The Royal London Hospital, London, Not set

Christie Hospital, Manchester, Not set

Local Institution - 252, Oxford, Not set

Oxford University Hospitals NHS Trust- Churchill Hospital-Oxford Centre for Respiratory Medicine, Oxford, Not set

Local Institution - 253, Sutton (Surrey), Not set

Royal Marsden Hospital, Sutton (Surrey), Not set

The Royal Wolverhampton Hospital NHS Trust, Wolverhampton, Not set

Conditions: Multiple Myeloma

Learn More ›

Trial of Immunomodulatory Therapy in High Risk Solitary Bone Plasmacytoma

NCT02544308

Active Not Recruiting

The purpose of the trial is to establish whether adjuvant therapy with lenalidomide + dexamethasone after radiotherapy can improve progression free survival in patients with high risk solitary bone plasmacytoma compared with RT only.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

12/22/2022

Locations: Royal United Hospital, Bath, Not set +12 locations

Conditions: Plasmacytoma

Learn More ›

Efficacy and Safety Study of bb2121 Versus Standard Regimens in Subjects With Relapsed and Refractory Multiple Myeloma (RRMM)

NCT03651128

Active Not Recruiting

This is a multicenter, randomized, open-label, Phase 3 study comparing the efficacy and safety of bb2121 versus standard regimens in subjects with relapsed and refractory multiple myeloma (RRMM). The study is anticipated to randomize approximately 381 subjects with RRMM. Approximately 254 subjects will be randomized to Treatment Arm A and approximately 127 subjects will be randomized to Treatment Arm B.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

12/13/2022

Locations: Local Institution - 109, Birmingham, Alabama +59 locations

Local Institution - 109, Birmingham, Alabama

Local Institution - 141, Scottsdale, Arizona

Local Institution - 145, Los Angeles, California

Local Institution - 122, Los Angeles, California

Local Institution - 124, Palo Alto, California

Local Institution - 142, Aurora, Colorado

Local Institution - 108, Jacksonville, Florida

Local Institution - 102, Tampa, Florida

Local Institution - 131, Atlanta, Georgia

Local Institution - 140, Atlanta, Georgia

Local Institution - 139, Chicago, Illinois

Local Institution - 100, Indianapolis, Indiana

Local Institution - 112, Westwood, Kansas

Local Institution - 104, Baltimore, Maryland

Local Institution - 134, Boston, Massachusetts

Local Institution - 123, Boston, Massachusetts

University Of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan

Local Institution - 125, Rochester, Minnesota

Local Institution - 114, Saint Louis, Missouri

Local Institution - 138, Hackensack, New Jersey

Local Institution - 119, New York, New York

Local Institution - 115, New York, New York

Local Institution - 135, New York, New York

Local Institution - 113, Durham, North Carolina

Local Institution - 111, Philadelphia, Pennsylvania

Local Institution - 110, Philadelphia, Pennsylvania

University of Pittsburgh Medical Center William M. Cooper Ambulatory Care Pavillion, Pittsburgh, Pennsylvania

Local Institution - 106, Nashville, Tennessee

Local Institution - 118, Dallas, Texas

Local Institution - 103, Dallas, Texas

Local Institution - 132, Houston, Texas

Local Institution - 136, Salt Lake City, Utah

Local Institution - 105, Seattle, Washington

Local Institution - 107, Madison, Wisconsin

Local Institution - 202, Leuven, Not set

Local Institution - 302, Calgary, Alberta

Local Institution - 303, Toronto, Ontario

Local Institution - 402, Lille Cedex, Not set

Local Institution - 403, Nantes, Not set

Local Institution - 400, Paris, Not set

Local Institution - 401, Toulouse CEDEX 9, Not set

Local Institution - 513, Dusseldorf, Not set

Local Institution - 514, Hamburg, Not set

Local Institution - 512, Heidelberg, Not set

Local Institution - 515, Köln, Not set

Local Institution - 511, Würzburg, Not set

Local Institution - 611, Bologna, Not set

Local Institution - 806, Bunkyo-ku, Not set

Local Institution - 804, Isehara City, Kanagawa, Not set

Local Institution - 807, Nagoya, Not set

Local Institution - 805, Shibuya-ku, Not set

Local Institution - 650, Amsterdam, Not set

Local Institution - 651, Rotterdam, Not set

Local Institution - 700, Oslo, Not set

Local Institution - 750, Pamplona, Not set

Local Institution - 751, Salamanca, Not set

Local Institution - 800, Stockholm, Not set

Local Institution - 251, Bern, Not set

Local Institution - 850, Leeds, Not set

Local Institution - 851, London, Not set

Conditions: Multiple Myeloma

Learn More ›

A Study of Ixazomib, Given With Dexamethasone in Adults With Multiple Myeloma

NCT03170882

Completed

The main aim of this study is to learn if ixazomib, given with dexamethasone, stops the cancer from getting worse in people with relapsed or refractory multiple myeloma. It will be compared to another medicine called pomalidomide, given with dexamethasone with people with the same condition. Relapsed means the previous cancer treatment stopped working, over time. Refractory means they did not respond to previous cancer treatment. Another aim is to check for side effects from the study medicines.... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

11/21/2022

Locations: Highlands Oncology Group, Fayetteville, Arkansas +110 locations

Highlands Oncology Group, Fayetteville, Arkansas

St Joseph Heritage Healthcare, Santa Rosa, California

Lynn Cancer Institute, Boca Raton, Florida

University of Florida, Gainesville, Florida

University of Maryland, Baltimore, Maryland

Henry Ford Health System, Detroit, Michigan

Michigan State University, Lansing, Michigan

Mayo Clinic, Rochester, Minnesota

San Juan Oncology Associates, Farmington, New Mexico

University of Toledo Medical Center, Toledo, Ohio

Icon Cancer Care South Brisbane, South Brisbane, Queensland

The Queen Elizabeth Hospital, Woodville South, South Australia

Box Hill Hospital, Box Hill, Victoria

St Vincents Hospital Melbourne, Fitzroy, Victoria

Royal Adelaide Hospital, Adelaide, Not set

GasthuisZusters Antwerpen, Wilrijk, Antwerpen

AZ St Jan Brugge Oostende AV, Brugge, Not set

Royal Victoria Regional Health Centre, Barrie, Ontario

Lakeridge Health Center, Ottawa, Ontario

Fakultni nemocnice Hradec Kralove, Hradec Kralove, Kralovehradeck Kraj

University Hospital Olomouc, Olomouc, Olomouck Kraj

Fakultni nemocnice Kralovske Vinohrady, Prague, Praha, Hlavni Mesto

Vseobecna fakultni nemocnice v Praze, Praha, Praha, Hlavni Mesto

Fakultni nemocnice Brno, Brno, Not set

Fakultni nemocnice Ostrava, Ostrava, Not set

Fakultni nemocnice Plzen, Plzen Lochotin, Not set

Aalborg Universitetshospital, Aalborg, Nordjylland

Regionshospitalet Holstebro, Holstebro, Not set

Centre Antoine Lacassagne Centre Regional de Lutte Contre Le Cancer, Nice, Alpes-Maritimes

CHRU Dijon Complexe Du Bocage, Dijon, Cote-d'Or

CHRU de Brest - Hopital Morvan, Brest, Finistere

CHRU Nancy, Vandoeuvre Les Nancy, Meurthe-et-Moselle

Centre Hospitalier Bretagne Atlantique Vannes, Vannes, Morbihan

Centre Hospitalier Le Mans, Le Mans, Sarthe

Groupe Hospitalier du Havre, Montivilliers, Seine-Maritime

CHU Amiens Hopital Sud, Amiens, Not set

Centre Hospitalier Fleyriat, Bourg-en- Bresse Cedex, Not set

Centre Hospitalier (CH) William Morey, Chalon sur Saone, Not set

Hospital d Instructions des Armees Percy, Clamart, Not set

Centre Hospitalier de Dunkerque, Dunkerque, Not set

Centre Jean Bernard Clinique Victor Hugo, Le Mans cedex 2, Not set

Centre Hospitalier Regional d'Orleans, Orleans, Not set

Centre Hospitalier de Perigueux, Perigueux, Not set

CHRU de Poitiers La Miletrie, Poitiers, Not set

CHRU Rennes, Rennes Cedex 9, Not set

Centre Henri Becquerel, Rouen, Not set

Uberortliche Gemeinschaftspraxis Pasing und Furstenfeldbruck, Munchen, Bayern

Universitatsklinikum Dusseldorf, Dusseldorf, Not set

Asklepios Klinik Altona, Hamburg, Not set

Universitatsklinikum Tubingen, Tubingen, Not set

University General Hospital of Patras, Patra, Achaia

University Hospital of Alexandroupolis, Alexandroupoli, Not set

Evangelismos General Hospital of Athens, Athens, Not set

Alexandra Hospital, Athens, Not set

University General Hospital of Ioannina, Ioannina, Not set

Theageneio Anticancer Oncology Hospital of Thessaloniki, Thessaloniki, Not set

Soroka University Medical Centre, Beer Sheva, Not set

Bnai Zion Medical Center, Haifa, Not set

Rambam Health Corporation, Haifa, Not set

Lady Davis Carmel Medical Center, Haifa, Not set

Hadassah Medical Center, Jerusalem, Not set

Azienda Ospedaliero Universitaria Di Bologna - Policlinico S Orsola Malpighi, Bologna, Emilia-Romagna

Ospedale Santa Maria Delle Croci, Ravenna, Emilia-Romagna

Arcispedale Santa Maria Nuova, Reggio Emilia, Emilia-Romagna

Ospedale Infermi di Rimini, Rimini, Emilia-Romagna

Azienda Ospedaliera Ospedali Riuniti Marche Nord, Pesaro, Marche

Fondazione del Piemonte per lOncologia (IRCCS), Candiolo, Piemonte

Azienda Sanitaria Ospedaliera S Luigi Gonzaga, Orbassano, Piemonte

Azienda Ospedaliera Citta della Salute e della Scienza di Torino, Torino, Piemonte

Centro Di Riferimento Oncologico Della Basilicata, Rionero in Vulture, PZ

Centro Di Riferimento Oncologico, Aviano, Not set

ASST degli Spedali Civili di Brescia - Spedali Civili di Brescia, Brescia, Not set

Istituto Scientifico Romagnolo Per Lo Studio E La Cura Dei Tumori IRST, Meldola, Not set

Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico, Milano, Not set

Azienda Ospedaliero Universitaria Di Modena Policlinico, Modena, Not set

Azienda Ospedaliero Universitaria di Parma, Parma, Not set

Ospedale Santa Maria Della Misericordia, Udine, Not set

Azienda ULSS 6 Vicenza, Vicenza, Not set

Albert Schweitzer Ziekenhuis, Dordrecht, Zuid-Holland

Zuyderland Medisch Centrum, Sittard, Not set

Oslo Universitetssykehus HF Rikshospitalet, Oslo, Oppland

Haukeland Universitetssykehus, Bergen, Not set

Forde Sentralsjukehus, Forde, Not set

Stavanger Universitetssykehus, Stavanger, Not set

St Olavs Hospital, Trondheim, Not set

Kirov Research Institute of Haematology and Blood Transfusion, Kirov, Not set

Moscow Clinical Scientific Center, Moscow, Not set

City Clinical Hospital n a S P Botkin, Moscow, Not set

City Clinical Hospital # 40, Moscow, Not set

Samara State Medical University, Samara, Not set

Hospital Universitario Infanta Leonor, Madrid, Madrid, Communidad Delaware

Hospital Universitari de Girona Dr Josep Trueta, Girona, Not set

Hospital Clinico Universitario de Valencia, Valencia, Not set

Helsingborg Lasarett, Helsingborg, Skane Lan

Sodra Alvsborgs Sjukhus Boras, Boras, Not set

Norrlands Universitetssjukhus, Umea, Not set

Dr. Abdurrahman Yurtaslan Ankara Onkoloji Egitim ve Arastirma Hastanesi, Ankara, Not set

Gazi University Medical Faculty Gazi Hospital, Ankara, Not set

Ankara University Medical Faculty Cebeci Hospital, Ankara, Not set

Dokuz Eylul University Medical Faculty, Izmir, Not set

Ege Universitesi Tip Fakultesi Hastanesi, Izmir, Not set

Erciyes Universitesi Tip Fakultesi Hastanesi, Kayseri, Not set

Royal Cornwall Hospital, Truro, Cornwall

Betsi Cadwaladr University Health Board, Bodelwyddan, Denbighshire-SirDdinbych

Royal Bournemouth Hospital, Bournemouth, Dorset

Kent and Canterbury Hospital, Canterbury, Kent

GenesisCare Oxford, Oxford, Oxfordshire

Royal Stoke University Hospital, Stoke-on-Trent, Staffordshire

Leicester Royal Infirmary, Leicester, Not set

Singleton Hospital, Swansea, Not set

New Cross Hospital, Wolverhampton, Not set

Conditions: Relapsed and/or Refractory Multiple Myeloma

Learn More ›

Phase 3 Study With Carfilzomib and Dexamethasone Versus Bortezomib and Dexamethasone for Relapsed Multiple Myeloma Patients

NCT01568866

Completed

The primary objective of this study was to compare progression-free survival in patients with multiple myeloma who relapsed after 1 to 3 prior therapies treated with carfilzomib plus dexamethasone or bortezomib plus dexamethasone.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

11/10/2022

Locations: Providence St. Joseph Medical Center, Burbank, California +240 locations

Providence St. Joseph Medical Center, Burbank, California

UCSD Moore Cancer Center, La Jolla, California

UCLA Medical Center, Los Angeles, California

Central Coast Medical Oncology Group, Santa Maria, California

Colorado Blood Cancer Institute, Denver, Colorado

MAB Oncology/Hematology, Melbourne, Florida

Palm Beach Cancer Institute, West Palm Beach, Florida

Winship Cancer Institute, Atlanta, Georgia

Hematology Oncology of Indiana, PC, Indianapolis, Indiana

Center for Cancer and Blood Disorders, Bethesda, Maryland

Associates in Oncology/Hematology PC, Rockville, Maryland

University of Michigan, Ann Arbor, Michigan

University of Kansas, Kansas City, Missouri

Hackensack University Medical Ctr, Hackensack, New Jersey

Montefiore Medical Center, Bronx, New York

Clinical Research Alliance Inc., New York, New York

Weill Cornell Medical College, New York, New York

Wake Forest University Health Sciences, Section on Hematology and Oncology, Winston-Salem, North Carolina

Gabrail Cancer Center, Canton, Ohio

The Christ Hospital, Cincinnati, Ohio

Western Pennsylvania Hospital, Pittsburgh, Pennsylvania

Hematology/Oncology Associates of SC, Greenville, South Carolina

Vanderbilt Ingram Cancer Center, Nashville, Tennessee

MD Anderson, Houston, Texas

The Methodist Cancer Center, Houston, Texas

Scott & White Memorial Hospital, Temple, Texas

University of Utah School of Medicine, Salt Lake City, Utah

Royal Prince Alfred Hospital, Camperdown, New South Wales

St. Vincent's Public Hospital Sydney, Darlinghurst, New South Wales

Saint George Hospital, Kogarah, New South Wales

Liverpool Hospital, Liverpool, New South Wales

Royal North Shore Hospital, Saint Leonards, New South Wales

Calvary Mater Newcastle, Waratah, New South Wales

Westmead Hospital, Westmead, New South Wales

Royal Brisbane and Women's Hospital, Herston, Queensland

Haematology & Oncology Clinics of Australia, South Brisbane, Queensland

Haematology and Oncology Clinics of Australia at Chermside, South Brisbane, Queensland

Haematology and Oncology Clinics of Australia at Wesley, South Brisbane, Queensland

Royal Adelaide Hospital, Adelaide, South Australia

The Queen Elizabeth Hospital, Woodville, South Australia

Box Hill Hospital, Box Hill, Victoria

Monash Medical Centre, Clayton, Victoria

Saint Vincent's Hospital, East Melbourne, Victoria

Western Hospital, Footscray, Victoria

The Alfred Hospital, Melbourne, Victoria

Sunshine Hospital, St. Albans, Victoria

Fremantle Hospital, Fremantle, Western Australia

Royal Perth Hospital, Perth, Western Australia

Medizinische Universität Innsbruck, Innsbruck, Tyrol

Krankenhaus der Elisabethinen Linz, I Interne Abteilung, Linz, Upper Austria

Wilhelminenspital der Stadt Wien, Wien, Vienna

Universitair Ziekenhuis Leuven, Leuven, Flemish Brabant

Cliniques Universitaires UCL de Mont-Godinne, Yvoir, Namur

Universitair Ziekenhuis Gent, Ghent, Oost-vlaanderen

Ziekenhuis Netwerk Antwerpen, Antwerp, Not set

Cliniques Universitaires Saint Luc, Brussels, Not set

Universitair Ziekenhuis Brussel, Brussels, Not set

Liga Norte Riograndense Contra o Câncer, Natal, RIO Grande DO Norte

Clínica de Oncologia de Porto Alegre, Porto Alegre, RIO Grande DO SUL

Hospital de Clínicas de Porto Alegre, Porto Alegre, RIO Grande DO SUL

Hospital São Lucas da PUCRS, Porto Alegre, RIO Grande DO SUL

Hemocentro Campinas-Unicamp, Campinas, SAO Paulo

Hospital Universitário Clementino Fraga Filho da Universidade Federal do Rio de Janeiro, Rio de Janeiro, Not set

Instituto Centros Oncológicos Integrados de Educação e Pesquisa, Rio de Janeiro, Not set

Instituto Nacional do Câncer-INCA, Rio de Janeiro, Not set

Irmandade da Santa Casa de Misericórdia de São Paulo, São Paulo, Not set

Military Medical Academy Hospital for Active Treatment, Sofia, Sofiya

Shato, Ead, Sofia, Sofiya

University Multiprofile Hospital for Active Treatment "Sveti Georgi" EAD, Plovdiv, Not set

Multiprofile Hospital for Active Treatment, "Sveta Marina'', Varna, Not set

University of Alberta Hospital, Edmonton, Alberta

British Columbia Cancer Agency, Kelowna, British Columbia

Saint John Regional Hospital, Saint John, New Brunswick

Queen Elizabeth II Health Science Centre, Halifax, Nova Scotia

London Health Sciences Centre, London, Ontario

The Ottawa Hospital Regional Cancer Centre, Ottawa, Ontario

Windsor Regional Hospital, Windsor, Ontario

Hopital Maisonneuve-Rosemont, Montréal, Quebec

Fakultní nemocnice Královské Vinohrady, Praha 10, Praha

Fakultní nemocnice Olomouc, Olomouc, Severomoravsky KRAJ

FN Ostrava, Ostrava, Severomoravsky KRAJ

Fakultní nemocnice Hradec Králové, Hradec Kralové, Vychodocesky KRAJ

Fakultní nemocnice Brno, Brno, Not set

Všeobecná fakultní nemocnice v Praze, Praha, Not set

Centre Hospitalier de la Cote Basque, Bayonne, Aquitaine

Centre Hospitalier Universitaire Brest, Brest Cedex, Bretagne

Centre Hospitalier Universitaire de Rennes, Hôpital Pontchaillou, Rennes Cedex 9, Bretagne

Hopital Hotel-Dieu - Service d'Hematologie, Nantes, Cedex 1

Centre Henri-Becquerel, Rouen Cedex 1, Haute-normandie

Centre Hospitalier de Versailles, Le Chesnay, Ile-de-france

Hôpital Saint Louis, Paris, Ile-de-france

Hôpital Saint-Antoine, Paris, Ile-de-france

Hôpital Claude Huriez, Lille Cedex, NORD Pas-de-calais

Hôpital Hôtel-Dieu, Nantes cedex 1, PAYS DE LA Loire

Institut Paoli Calmettes, Marseille Cedex 9, Provence Alpes COTE D'azur

Centre Hospitalier Lyon Sud, Pierre Bénite Cedex, Rhone-alpes

Universitätsklinik Heidelberg, Heidelberg, Baden-wuerttemberg

Universitätsklinikum Tübingen, Tübingen, Baden-wuerttemberg

Universitätsklinikum Ulm, Ulm, Baden-wuerttemberg

Medizinische Klinik der Universität Würzburg, Würzburg, Bayern

Medizinische Hochschule Hannover, Hannover, Niedersachsen

Universitätsklinikum Aachen, Aachen, Nordrhein-westfalen

Universitätsklinikum Münster, Münster, Nordrhein-westfalen

Universitätsmedizin der Johannes Gutenberg Universität, Mainz, Rheinland-pfalz

Universitätsklinikum des Saarlandes, Homburg / Saar, Saarland

Klinikum Chemnitz gGmbH, Chemnitz, Sachsen

Universitätsklinikum Carl Gustav Carus, Med. Klinik und Poliklinik I, Dresden, Sachsen

Universitätsklinikum Leipzig, Leipzig, Sachsen

Universitätsklinikum Jena, Jena, Thuringen

Universitatsklinikum Freiburg, Freiburg, Not set

Universitätsklinikum Hamburg Eppendorf, Hamburg, Not set

Alexandra General Hospital, Athens, Attica

Bács-Kiskun Megyei Kórház Szegedi Tudományegyetem Általános Orvostudományi Kar Oktató Kórháza, Kecskemét, Bacs-kiskun

Pécsi Tudományegyetem, Pécs, Baranya

Szegedi Tudományegyetem, Szeged, Csongrad

Debreceni Egyetem Klinikai Központ, Debrecen, Hajdu-bihar

Egyesített Szent István és Szent László Kórház-Rendelointézet, Budapest, Not set

Somogy Megyei Kaposi Mac okato Korhoz, Kaposvár, Not set

Somogy Megyei Kaposi Mór Oktató Kórház, Kaposvár, Not set

Rambam Health Corp., Haifa, Not set

Hadassah Medical Center, Jerusalem, Not set

Meir Medical Center, Kfar Saba, Not set

Tel Aviv Sourasky Medical Center, Tel Aviv, Not set

The Chaim Sheba Medical Center at Tel Hashomer, Tel Hashomer, Not set

IRCCS Centro di Riferimento Oncologico di Basilicata di Rionero in Vulture, Rionero in Vulture, Potenza

Azienda Ospedaliero-Univesitaria San Luigi Gonzaga, Orbassano, Torino

Azienda Ospedaliero Universitaria Ospedali Riuniti di Ancona, Ancona, Not set

Azienda Ospedaliero-Universitaria di Bologna - Policlinico S.Orsola-Malpighi, Bologna, Not set

Azienda Ospedaliera Spedali Civili di Brescia, Brescia, Not set

IRCCS Azienda Ospedaliera Universitaria San Martino, Genova, Not set

Azienda Ospedaliera Universitaria Maggiore della Carità, Novara, Not set

Azienda Unità Sanitaria Locale di Piacenza-Ospedale Guglielmo da Saliceto, Piacenza, Not set

Azienda Ospedaliera Pisana Ospedale Santa Chiara, Pisa, Not set

Aienda Policknico Umberto I di Roma, Roma, Not set

Azienda Policknico Umberto l di Roma, Roma, Not set

Università Tor Vergata Ospedale Sant Eugenio, Roma, Not set

Azienda Ospedaliera Universitaria Senese - Policlinico S. Maria alle Scotte, Siena, Not set

Azienda Ospedaliera Città della Salute e della Scienza di Torino, Torino, Not set

Nagoya City University Hospital, Nagoya City, Aichi

Toyohashi Municipal Hospital, Toyohashi, Aichi

National Hospital Organization Kyushu Cancer Center, Fukuoka-city, Fukuoka

Ogaki Municipal Hospital, Ogaki City, Gifu

Gunma University Hospital, Maebashi, Gunma

National Hospital Organization Nishigunma National Hospital, Shibukawa, Gunma

Sapporo Medical University Hospital, Sapporo, Hokkaido

Kobe City Medical Center General Hospital, Kobe, Hyogo

Tokai University Hospital, Isehara, Kanagawa

Niigata Cancer Center Hospital, Niigata-city, Niigata

Osaka University Hospital, Suita, Osaka

Saitama Medical Center, Kawagoe, Saitama

Tochigi Cancer Center, Utsunomiya, Tochigi

National Cancer Center Hospital, Chuo-ku, Tokyo

The Cancer Institute Hospital Of Japanese Foundation For Cancer Research, Koto-ku, Tokyo

Toranornon Hospital, Shinagawa, Tokyo

Tokyo Medical University Hospital, Shinjuku, Tokyo

National Hospital Organization Disaster Medical Center, Tachikawa, Tokyo

Kyushu University Hospital, Fukuoka, Not set

Social Insurance Kyoto Hospital of All Japan Federation of Social Insurance Associations, Kyoto, Not set

University Hospital, Kyoto Prefectural University of Medicine, Kyoto, Not set

National Hospital Organization Okayama Medical Center, Okayama, Not set

Tokushima Prefectural Central Hospital, Tokushima, Not set

Japanese Red Cross Medical Center, Tokyo, Not set

Gachon University Gil Medical Center, Incheon, Gyeonggi-Do

Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do

Pusan National University Hospital, Busan, Gyeongsangnam-Do

Kyungpook National University Hospital, Daegu, Not set

Asan Medical Center, Seoul, Not set

Samsung Medical Center, Seoul, Not set

Seoul National University Hospital, Seoul, Not set

Seoul Saint Mary's Hospital, Seoul, Not set

Severance Hospital, Yonsei University Health System, Seoul, Not set

North Shore Hospital, North Shore City, Auckland

Middlemore Hospital, Otahuhu, Auckland

Auckland City Hospital, Grafton, Aukland

Christchurch Hospital, Christchurch, Not set

Dunedin Hospital, Dunedin, Not set

Specjalistyczny Szpital Miejski im. Mikolaja Kopernika, Torun, Kujawsko-Pomorskie

Zamojski Szpital Niepubliczny Sp. z o.o., Zamosc, Lubelskie

Szpital Uniwersytecki w Krakowie, Krakow, Malopolskie

Instytut Hematologii i Transfuzjologii, Warszawa, Mazowieckie

Uniwersyteckie Centrum Kliniczne, Gdansk, Pomorskie

Samodzielny Publiczny Zaklad Opieki Zdrowotnej Zespól Szpitali Miejskich, Chorzów, Slaskie

Szpital Kliniczny Przemienienia Panskiego Uniwersytetu Medycznego im K. Marcinkowskiego w Poznaniu, Poznan, Wielkopolskie

Spitalul Universitar de Urgenta Bucuresti, Bucharest, Bucuresti

Policlinica de Diagnostic Rapid SA, Compartiment Medical Oncologie-Hematologie, Brasov, Not set

Spitalul Clinic Judetean de Urgenta Brasov (Bumbea, Horia), Brasov, Not set

Institutul Clinic Fundeni, Bucuresti, Not set

Institutul Regional de Oncologie Iasi, Iasi, Not set

Republican Clinical Hospital #1, Izhevsk, Not set

City Clinical Hospital n.a. S. P. Botkin, Moscow, Not set

Non-state Healthcare Institution "N.A. Semashko Central Clinical Hospital #2 of JSC "Russian Railway, Moscow, Not set

Ryazan Regional Clinical Hospital, Ryazan, Not set

Clinical Hospital Number 31, Saint Petersburg, Not set

Federal Almazov Medical Research Centre, Saint Petersburg, Not set

FGU Russian Scientific Research Institute of Hematology and Transfusiology, Saint Petersburg, Not set

First Saint Petersburg I.P. Pavlov State Medical University, Saint Petersburg, Not set

GUZ Samara Regional Clinical Hospital n.a. M.I. Kalinin, Samara, Not set

National University Cancer Institute, Singapore, Not set

Singapore General Hospital, Singapore, Not set

Singapore Oncology Consultants, Singapore, Not set

Univerzitná nemocnica Bratislava, Bratislava, Not set

Hospital Son Llàtzer, Palma de Mallorca, Baleares

Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona

Hospital Clinic I Provincial de Barcelona, Barcelona, Not set

Institut Universitari Dexeus, Barcelona, Not set

Centro Integral Oncológico Clara Campal, Hospital de Madrid Norte-San Chinarro, Madrid, Not set

Hospital Universitario 12 de Octubre, Madrid, Not set

Hospital Universitario La Princesa, Madrid, Not set

Hospital Clínico Universitario de Salamanca, Salamanca, Not set

Hospital Universitario Virgen del Rocio, Sevilla, Not set

Hospital Universitari i Politecnic La Fé de Valencia, Valencia, Not set

Chang Gung Memorial Hospital, Kaohsiung, Not set

China Medical University Hospital, Taichung, Not set

National Cheng-Kung University Hospital, Tainan, Not set

National Taiwan University Hospital, Taipei, Not set

Taipei Veterans General Hospital, Taipei, Not set

Chang Gung Medical Foundation-LinKou Branch, Tao-Yuan, Not set

King Chulalongkorn Memorial Hospital, Bangkok, Bangkok Metropolis

Ramathibodi Hospital, Bangkok, Bangkok Metropolis

Srinagarind Hospital, Khon Kaen, Not set

City Hematology Center, Dnepropetrovsk, Dnipropretrovsk

Municipal Institution of Health Protection "Clinical Hospital #8", Kharkov, Kharkiv

Cherkassy Regional Oncology Center, Cherkassy, Not set

MI "Dnipropetrovsk City Multifield Clinical Hospital #4" of Dnipropetrovsk Regional Council", City Hematology Center, Dnipropetrovsk, Not set

Institute of Urgent and Reparative Surgury of Ukraine Academy of Medical Sciences, Donetsk, Not set

Khmelnytsky Regional Clinical Hospital, Khmelnytsky, Not set

Khmelnytsky Regional Hospital, Department of Hematology, Khmelnytsky, Not set

National Institute of Cancer, Oncohematology Department, Kiev, Not set

Kyiv Bone Marrow Transplantation Center, Kyiv, Not set

Lviv Regional Oncology Dispensary, Lviv, Not set

Lviv State Oncology Regional Treatment-Prophylactic Center, Department of Chemotherapy, Lviv, Not set

Regional Clinical Hospital, Mykolayiv, Not set

Royal Free Hospital, London, England

University College Hospital, London, England

Manchester Royal Infirmary, Manchester, England

Nottingham University Hospitals NHS Trust, Nottingham, England

Churchill Hospital, Oxford, England

Derriford Hospital, Plymouth, England

Royal Hallamshire Hospital, Sheffield, England

Royal Marsden Hospital, Surrey, England

Royal Wolverhampton Hospitals Trust, Wolverhampton, England

Conditions: Multiple Myeloma

Learn More ›

A Safety and Efficacy Study of Ibrutinib in Pediatric and Young Adult Participants With Relapsed or Refractory Mature B-cell Non-Hodgkin Lymphoma

NCT02703272

Terminated

The purpose of this study is to confirm that the pharmacokinetics of ibrutinib in pediatric participants is consistent with that in adults (part 1) and to assess efficacy (event-free survival \[EFS\]) of ibrutinib in combination with rituximab, ifosfamide, carboplatin, and etoposide (RICE) or rituximab, vincristine, ifosfamide, carboplatin, and idarubicin (RVICI) background therapy compared to RICE or RVICI background therapy alone (part 2).

Gender:

ALL

Ages:

Between 1 year and 30 years

Trial Updated:

11/07/2022

Locations: Not set, Los Angeles, California +76 locations

Not set, Los Angeles, California

Not set, Orange, California

Not set, Palo Alto, California

Not set, Aurora, Colorado

Not set, Washington, District of Columbia

Not set, Atlanta, Georgia

Not set, Baltimore, Maryland

Not set, Boston, Massachusetts

Not set, New York, New York

Not set, Valhalla, New York

Not set, Charlotte, North Carolina

Not set, Cincinnati, Ohio

Not set, Columbus, Ohio

Not set, Philadelphia, Pennsylvania

Not set, Dallas, Texas

Not set, Salt Lake City, Utah

Not set, Milwaukee, Wisconsin

Not set, Brussel, Not set

Not set, Leuven, Not set

Not set, Barretos, Not set

Not set, Curitiba, Not set

Not set, Sao Paulo, Not set

Not set, São Paulo, Not set

Not set, Plovdiv, Not set

Not set, Sofia, Not set

Not set, Halifax, Nova Scotia

Not set, Toronto, Ontario

Not set, Brno, Not set

Not set, Praha, Not set

Not set, Bordeaux, Not set

Not set, Lille, Not set

Not set, Lyon, Not set

Not set, Marseille, Not set

Not set, Nantes, Not set

Not set, Toulouse, Not set

Not set, Vandoeuvre les Nancy, Not set

Not set, Villejuif, Not set

Not set, Berlin, Not set

Not set, Freiburg, Not set

Not set, Kiel, Not set

Not set, München, Not set

Not set, Münster, Not set

Not set, Budapest, Not set

Not set, Debrecen, Not set

Not set, Seoul, Not set

Not set, Rotterdam, Not set

Not set, Utrecht, Not set

Not set, Krakow, Not set

Not set, Warszawa, Not set

Not set, Wroclaw, Not set

Not set, Bucuresti, Not set

Not set, Cluj-Napoca, Not set

Not set, Oradea, Not set

Not set, Timisoara, Not set

Not set, Ekaterinburg, Not set

Not set, Moscow, Not set

Not set, St. Petersburg, Not set

Not set, Barcelona, Not set

Not set, Esplugues de Llobregat, Not set

Not set, Madrid, Not set

Not set, Valencia, Not set

Not set, Gothenburg, Not set

Not set, Kaohsiung, Not set

Not set, Taipei, Not set

Not set, Taoyuan, Not set

Not set, Ankara, Not set

Not set, Izmir, Not set

Not set, Kiev, Not set

Not set, Birmingham, Not set

Not set, Cambridge, Not set

Not set, Leeds, Not set

Not set, Liverpool, Not set

Not set, London, Not set

Not set, Manchester, Not set

Not set, Newcastle, Not set

Not set, Sheffield, Not set

Not set, Surrey, Not set

Conditions: Lymphoma, Non-Hodgkin

Learn More ›

Once-weekly Versus Twice-weekly Carfilzomib in Combination With Dexamethasone in Adults With Relapsed and Refractory Multiple Myeloma

NCT02412878

Completed

The purpose of the study is to compare the progression-free survival (PFS) of once-weekly carfilzomib dosing in combination with dexamethasone to twice-weekly carfilzomib dosing in combination with dexamethasone in adults with relapsed and refractory multiple myeloma, previously treated with bortezomib and an immunomodulatory agent (IMiD).

Gender:

ALL

Ages:

18 years and above

Trial Updated:

09/09/2022

Locations: Research Site, Scottsdale, Arizona +139 locations

Research Site, Scottsdale, Arizona

Mayo Clinic, Scottsdale, Arizona

Research Site, Bethesda, Maryland

Center for Cancer and Blood Disorders, Bethesda, Maryland

Research Site, Rockville, Maryland

Maryland Oncology Hematology, P.A, Rockville, Maryland

Research Site, Hackensack, New Jersey

John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey

Research Site, New York, New York

Research Site, Pittsburgh, Pennsylvania

Research Site, Tyler, Texas

Blood and Cancer Center of East Texas, Tyler, Texas

Research Site, Darlinghurst, New South Wales

Research Site, Tweed Heads, New South Wales

Research Site, Waratah, New South Wales

Research Site, Box Hill, Victoria

Research Site, Antwerpen, Not set

Research Site, Brugge, Not set

Research Site, Brussel, Not set

Research Site, Bruxelles, Not set

Research Site, Ghent, Not set

Research Site, Leuven, Not set

Research Site, Calgary, Alberta

Research Site, Kelowna, British Columbia

Research Site, Vancouver, British Columbia

Research Site, St. Johns, Newfoundland and Labrador

Research Site, Halifax, Nova Scotia

Research Site, Ottawa, Ontario

Research Site, Toronto, Ontario

Research Site, Montreal, Quebec

Research Site, Quebec, Not set

Research Site, Brno, Not set

Research Site, Hradec Kralove, Not set

Research Site, Olomouc, Not set

Research Site, Ostrava-Poruba, Not set

Research Site, Praha 10, Not set

Research Site, Praha, Not set

Research Site, Aalborg, Not set

Research Site, Copenhagen, Not set

Research Site, Odense C, Not set

Research Site, Vejle, Not set

Research Site, Helsinki, Not set

Research Site, Tampere, Not set

Research Site, Turku, Not set

Research Site, Bayonne, Not set

Research Site, Brest, Not set

Research Site, Dijon, Not set

Research Site, Nantes Cedex 1, Not set

Research Site, Nimes cedex 09, Not set

Research Site, Paris, Not set

Research Site, Pierre-Benite cedex, Not set

Research Site, Rennes, Not set

Research Site, Tours Cedex 1, Not set

Research Site, Köln, Not set

Research Site, Leipzig, Not set

Research Site, München, Not set

Research Site, Rostock, Not set

Research Site, Tubingen, Not set

Research Site, Athens, Not set

Research Site, Patra, Not set

Research Site, Budapest, Not set

Research Site, Debrecen, Not set

Research Site, Gyula, Not set

Research Site, Kaposvar, Not set

Research Site, Ancona, Not set

Research Site, Bologna, Not set

Research Site, Brescia, Not set

Research Site, Cagliari, Not set

Research Site, Catania, Not set

Research Site, Firenze, Not set

Research Site, Genova, Not set

Research Site, Napoli, Not set

Research Site, Pavia, Not set

Research Site, Piacenza, Not set

Research Site, Pisa, Not set

Research Site, Roma, Not set

Research Site, Torino, Not set

Research Site, Toyohashi-shi, Aichi

Research Site, Fukuoka-shi, Fukuoka

Research Site, Ogaki-shi, Gifu

Research Site, Maebashi-shi, Gunma

Research Site, Shibukawa-shi, Gunma

Research Site, Sapporo-shi, Hokkaido

Research Site, Isehara-shi, Kanagawa

Research Site, Kyoto-shi, Kyoto

Research Site, Sendai-shi, Miyagi

Research Site, Okayama-shi, Okayama

Research Site, Suita-shi, Osaka

Research Site, Kawagoe-shi, Saitama

Research Site, Utsunomiya-shi, Tochigi

Research Site, Chuo-ku, Tokyo

Research Site, Koto-ku, Tokyo

Research Site, Shibuya-ku, Tokyo

Research Site, Tachikawa-shi, Tokyo

Research Site, Fukuoka-shi, Not set

Research Site, Nagoya-shi, Not set

Research Site, Niigata-shi, Not set

Research Site, Tokushima-shi, Not set

Research Site, Christchurch, Not set

Research Site, Otahuhu, Auckland, Not set

Research Site, Oslo, Not set

Research Site, Trondheim, Not set

Research Site, Brzozow, Not set

Research Site, Chorzow, Not set

Research Site, Katowice, Not set

Research Site, Krakow, Not set

Research Site, Lodz, Not set

Research Site, Olsztyn, Not set

Research Site, Poznan, Not set

Research Site, Torun, Not set

Research Site, Warszawa, Not set

Research Site, Wroclaw, Not set

Research Site, Brazov, Not set

Research Site, Bucharest, Not set

Research Site, Sevilla, Andalucía

Research Site, Zaragoza, Aragón

Research Site, Palma de Mallorca, Baleares

Research Site, Salamanca, Castilla León

Research Site, Badalona, Cataluña

Research Site, Barcelona, Cataluña

Research Site, Girona, Cataluña

Research Site, Pamplona, Navarra

Research Site, Madrid, Not set

Research Site, Goteborg, Not set

Research Site, Helsingborg, Not set

Research Site, Lund, Not set

Research Site, Stockholm, Not set

Research Site, Uddevalla, Not set

Research Site, Bournemouth, Not set

Research Site, London, Not set

Research Site, Manchester, Not set

Research Site, Nottingham, Not set

Research Site, Sheffield, Not set

Research Site, Wolverhampton, Not set

Conditions: Multiple Myeloma

Learn More ›

Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma

NCT01080391

Completed

The primary objective was to compare progression-free survival in adults with relapsed multiple myeloma who are receiving CRd vs participants receiving Rd in a randomized multicenter setting.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

09/08/2022

Locations: Mayo Clinic, Scottsdale, Arizona +126 locations

Mayo Clinic, Scottsdale, Arizona

Providence St. Joseph Medical Center, Burbank, California

St. Jude Hospital Yorba Linda dba; St. Joseph Heritage Healthcare, Santa Rosa, California

Stanford University, Stanford, California

Colorado Blood Cancer Institute, Denver, Colorado

Cancer and Blood Disease Center, Lecanto, Florida

Rush University Medical Center, Chicago, Illinois

Indiana University Health Melvin and Bren Simon Cancer Center, Indianapolis, Indiana

University of Kansas Cancer Center, Kansas City, Kansas

The University of Michigan - Comprehensive Cancer Center, Ann Arbor, Michigan

Mayo Clinic, Rochester, Minnesota

John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey

NYU Clinical Cancer Center, New York, New York

Weill Cornell Medical College, New York, New York

Associates in Oncology and Hematology, Chattanooga, Tennessee

The Don & Sybil Harrington Cancer Center, Amarillo, Texas

Baylor Sammons Cancer Center, Dallas, Texas

UT Southwestern Medical Center at Dallas, Dallas, Texas

The University of Texas, MD Anderson Cancer Center, Houston, Texas

Scott and White Memorial Hospital, Temple, Texas

Fred Hutchinson Cancer Research Center, Seattle, Washington

Froedtert & Medical College of Wisconsin, Milwaukee, Wisconsin

Medizinische Universitat Wien, Wien, Not set

Wilhelminspital der Stadt Wien, Zentrum fur Onkologie und Hamatologie, Wien, Not set

Ziekenhuisnetwerk Antwerpen - AZ Stuivenberg, Antwerpen, Not set

AZ Sint-Jan AV, Brugge, Not set

UZ Brussel, Brussels, Not set

Institut Jules Bordet, Bruxelles, Not set

Cliniques Universitaires Saint-Luc, Bruxelles, Not set

UZ Leuven, Leuven, Not set

University Multiprofile Hospital for Active Treatment, "Dr. Georgi Stranski", Pleven, Not set

University Multiprofile Hospital for Active Treatment "Sveti Georgi", Plovdiv, Not set

Military Medical Academy Multiprofile Hospital for Active Treatment, Sofia, Not set

Specialized Hospital for Active Treatment of Hematological Diseases, Sofia, Not set

Multiprofile Hospital for Active Treatment "Sveta Marina", Varna, Not set

Tom Baker Cancer Centre, Calgary, Alberta

University of Alberta, Cross Cancer Institute, Edmonton, Alberta

Vancouver General Hospital, Vancouver, British Columbia

Cancer Care Manitoba, Winnipeg, Manitoba

General Hospital, Health Sciences Centre, St John's, Newfoundland and Labrador

Princess Margaret Hospital, Toronto, Ontario

McGill University Health Center, Royal Victoria Hospital, Montreal, Quebec

Sir Mortimer B. Davis - Jewish General Hospital, Montreal, Quebec

University Hospital Brno, Department of Internal Medicine - Hematooncology, Brno, Not set

University Hospital Hradec Kralove, Hradec Kralove, Not set

University Hospital Olomouc, Olomouc, Not set

University Hospital Kralovske Vinohrady - Prague, Praha 10, Not set

General University Hospital Prague, Praha 2, Not set

Hospital Antoine Beclere, Clamart, Not set

Clinique Victor Hugo - Centre Jean Bernard, Le Mans, Not set

Hopital Claude Huriez, Lille, Not set

CH de Mulhouse, Hopital Emile Muller, Mulhouse, Not set

CHU Nantes Hotel Dieu, Nantes, Not set

Hopital Saint-Antoine, Paris, Not set

Groupe Hospitalier Necker - Enfants Malades, Paris, Not set

Cancer Institut Universitaire de Toulouse-Oncopole (iUCT), Toulouse, Not set

Hopitaux de Brabois, Vandoeuvre-Les-Nancy, Not set

University of Dusseldorf, Dusseldorf, Not set

Krankenhaus Nordwest, Frankfurt am Main, Not set

University of Hamburg-Eppendorf, Hamburg, Not set

Universitat Heidelberg, Heidelberg, Not set

Stiftungsklinikum Mittelrhein, Koblenz, Not set

LMU Klinikum der Universitat, Munchen, Not set

Universitatsklinikum Munster, Munster, Not set

Universitatsklinikum Wurzburg, Wurzburg, Not set

Alexandra Hospital, Athens, Not set

University General Hospital of Patras, Patras, Not set

St. Istvan and St. Laszlo Hospital of Budapest, Budapest, Not set

University of Debrecen, Medical and Health Science Center, Debrecen, Not set

Petz Aladar County Teaching Hospital, Gyor, Not set

Bekes County Pandy Kalman Hospital, Gyula, Not set

Kaposi Mor County Teaching Hospital, Kaposvar, Not set

University of Pecs, Pecs, Not set

University of Szeged, Albert Szent-Gyorgi Clinical Center, Szeged, Not set

Rambam Medical Center, Haifa, Not set

Hadassah Medical Center, Ein Kerem, Jerusalem, Not set

Western Gailee Hospital - Nahariya, Nahariya, Not set

Rabin Medical Center, Petach Tikva, Not set

The Chaim Sheba Medical Center, Ramat Gan, Not set

Kaplan Medical Center, Rehovot, Not set

Azienda Ospedallera Niguarda Ca Granda, Milano, Not set

Azienda Ospedllero Maggiore della Carita, Novara, Not set

Azienda Ospedaliera Pisana Ospendale Santa Chiara - Main, Pisa, Not set

Ospedale S. Eugenio, Roma, Not set

Azienda Ospedaliera Citta della Salute e della Scienza di Torino, Torino, Not set

Erasmus MC, Department of Haematology, Rotterdam, Not set

University Clinical Centre, Department of Hematologii Transplantologii, Gdansk, Not set

Samodzielny Publ. Szp. Wojewodzki w Gorzow Wlkp., Gorzow Wielkopolski, Not set

Independent Public Teaching Hospital of Medical University of Silesia in Katowice, Katowice, Not set

Nicolaus Copernicus Memorial Provincial Specialist Hospital in Lodz, Lodz, Not set

Szpital Wojewwodzki im. dr Ludwika Rydygiera w Suwalkach, Suwalki, Not set

Nicolaus Copernicus Municipal Specialist Hospital, Torun, Not set

Maria Sklodowska-Curie Institute of Oncology, Warszawa, Not set

Zamojski Non-Public Hospital, Zamosc, Not set

Fundeni Clinical Institute, "Stefan Berceanu" Center for Hematology and Bone Marrow Transplantation, Bucharest, Not set

Coltea Clinical Hospital, Bucharest, Not set

Bucharest University Emergency Hospital, Bucharest, Not set

Regional Institute of Iasi, Iasi, Not set

State Medical Institution Komi Republican Oncological Center, Syktyvkar, Komi Republic

First Republican Clinical Hospital under the Ministry of Healthcare of the Republic of Udmurtia, Izhevsk, Not set

Federal State Budgetary Scientific Institution: N.N. Blokhin Russian Cancer Research Center, Moscow, Not set

Moscow State Medical Institution Municipal City Clinical Hospital n.a. S.P. Botkin, Moscow, Not set

Federal State Budget Institution: Hematology Research Center under MoH, Moscow, Not set

FSBI: Russian Research Institute of Hematology and Blood Transfusion under the Ferderal Agency for M&B, St. Petersburg, Not set

State Higher Educational Institution: St Petersburg State Medical University n.a.I.P Pavlov, St. Petersburg, Not set

SHEI: First St. Petersburg State Medical University N.a.I.P Pavlov under MoH, Clinic of Bone Marrow Transplant, St. Petersburg, Not set

Federal State Budget Institute: Federal Almalov Medical Research Centre under Ministry of Healthcare, St. Petersburg, Not set

Clinical Center of Serbia, Clinic of Hematology, Belgrade, Not set

Clinical Hospital Center Bezanijska Kosa, Belgrade, Not set

Military Medical Academy, Clinic of Hematology, Belgrade, Not set

Clinical Center Nis, Clinic of Hematology, Nis, Not set

Clinical Center of Vojvodina, Clinic of Hematology, Novi Sad, Not set

Hospital Universitario Germans Trias i Pujol, Badalona, Not set

Hospital Clinic I Provincial, Barcelona, Not set

Hospital Universitario de Salamanca, Salamanca, Not set

Hospital Donostia, San Sebastian, Not set

Hospital Universitario y Politeecnico La Fe, Valencia, Not set

Hospital Universitario Miguel Servet, Zaragoza, Not set

Sahlgrenska Universitetssjukhuset, Goteborg, Not set

Karolinska Universitetsjukhuset i Huddinge, Stockholm, Not set

Karolinska Universitetssjukhuset Solna, Hematologiskt Centrum, Stockholm, Not set

St. Bartholomew's Hospital, London, Not set

Royal Free Hampstead, London, Not set

St. Georges Hospital, London, Not set

Nottingham University Hospitals (City Campus), Nottingham, Not set

Royal Marsden Hospital, Sutton, Not set

The Royal Wolverhampton Hospital NHS Trust, Wolverhampton, Not set

Conditions: Relapsed Multiple Myeloma

Learn More ›

Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Newly Diagnosed, Previously Untreated Multiple Myeloma

NCT01335399

Completed

The purpose of the study is to determine whether the addition of Elotuzumab to Lenalidomide/low-dose Dexamethasone will increase the progression free survival (PFS)

Gender:

ALL

Ages:

18 years and above

Trial Updated:

09/02/2022

Locations: Local Institution - 1628, Birmingham, Alabama +234 locations

Local Institution - 1628, Birmingham, Alabama

Local Institution - 7619, Mobile, Alabama

Local Institution - 7618, Mobile, Alabama

Local Institution - 7617, Chandler, Arizona

Local Institution - 1644, Tucson, Arizona

Local Institution - 1618, Bakersfield, California

Local Institution - 1602, Berkeley, California

Local Institution - 1636, Corona, California

Local Institution - 1668, Corona, California

Local Institution - 1616, Greenbrae, California

Local Institution - 7609, Long Beach, California

Local Institution - 1660, Los Angeles, California

Local Institution - 1673, Orange, California

Local Institution - 1613, San Diego, California

Local Institution - 1621, New Haven, Connecticut

Local Institution - 1612, Washington, District of Columbia

Local Institution - 1682, Boca Raton, Florida

Local Institution - 1617, Brooksville, Florida

Local Institution - 1648, Fort Myers, Florida

Local Institution - 7613, Hollywood, Florida

Local Institution - 1623, Jacksonville, Florida

Local Institution - 1625, New Port Richey, Florida

Local Institution - 1649, Saint Petersburg, Florida

Local Institution - 1611, West Palm Beach, Florida

Local Institution - 1630, Atlanta, Georgia

Local Institution - 1684, Honolulu, Hawaii

Local Institution - 1607, Chicago, Illinois

Local Institution - 1635, Chicago, Illinois

Local Institution - 1632, Maywood, Illinois

Local Institution - 7606, Peoria, Illinois

Local Institution - 7610, Skokie, Illinois

Local Institution - 1603, Urbana, Illinois

Local Institution - 7616, Bloomington, Indiana

Local Institution - 7620, Indianapolis, Indiana

Local Institution - 1669, Indianapolis, Indiana

Local Institution - 1656, Mishawaka, Indiana

Local Institution - 1633, Iowa City, Iowa

Local Institution - 1674, Lexington, Kentucky

Local Institution - 1683, Louisville, Kentucky

Local Institution - 1646, Lafayette, Louisiana

Local Institution - 7614, Marrero, Louisiana

Local Institution - 1626, New Orleans, Louisiana

Local Institution - 1652, Shreveport, Louisiana

Local Institution - 1676, Baltimore, Maryland

Local Institution - 1650, Baltimore, Maryland

Local Institution - 1619, Boston, Massachusetts

Local Institution - 1699, Boston, Massachusetts

Local Institution - 1604, Detroit, Michigan

Local Institution - 1667, Jefferson City, Missouri

Local Institution - 1645, Saint Louis, Missouri

Local Institution - 1651, Springfield, Missouri

Local Institution - 1637, Omaha, Nebraska

Local Institution - 7621, Mineola, New York

Local Institution - 1615, New York, New York

Local Institution - 1671, Stony Brook, New York

Local Institution - 7604, Goldsboro, North Carolina

Local Institution - 1610, Winston-Salem, North Carolina

Local Institution - 1608, Cleveland, Ohio

Local Institution - 1693, Cleveland, Ohio

Local Institution - 1638, Columbus, Ohio

Local Institution - 1664, Columbus, Ohio

Local Institution - 1690, Middletown, Ohio

Local Institution - 1655, Tulsa, Oklahoma

Local Institution - 7611, Langhorne, Pennsylvania

Local Institution - 1647, Pittsburgh, Pennsylvania

Local Institution - 1679, Pittsburgh, Pennsylvania

Local Institution - 1677, Sayre, Pennsylvania

Local Institution - 1629, Charleston, South Carolina

Local Institution - 7615, Charleston, South Carolina

Local Institution - 1624, Greenville, South Carolina

Local Institution - 7607, Sioux Falls, South Dakota

Local Institution - 1600, Knoxville, Tennessee

Local Institution - 7628, Memphis, Tennessee

Local Institution - 1627, Nashville, Tennessee

Local Institution - 1670, Nashville, Tennessee

Local Institution - 1634, Corpus Christi, Texas

Local Institution - 7612, Dallas, Texas

Local Institution - 1643, Houston, Texas

Local Institution - 1686, Houston, Texas

Local Institution - 1642, Houston, Texas

Local Institution - 7623, Ogden, Utah

Local Institution - 1657, Fredericksburg, Virginia

Local Institution - 1640, Seattle, Washington

Local Institution - 1631, Seattle, Washington

Local Institution - 1601, Huntington, West Virginia

Gundersen Clinic, Ltd, La Crosse, Wisconsin

Local Institution - 1663, Madison, Wisconsin

Local Institution - 1609, Madison, Wisconsin

Local Institution - 3600, Garran, Australian Capital Territory

Local Institution - 3607, Waratah, New South Wales

Local Institution - 3610, Westmead, New South Wales

Local Institution - 3609, Herston, Queensland

Local Institution - 3608, Milton, Queensland

Local Institution - 3612, Adelaide, South Australia

Local Institution - 3606, Woodville South, South Australia

Local Institution - 3601, Fitzroy, Victoria

Local Institution - 3602, Frankston, Victoria

Local Institution - 3603, Heidelberg Melbourne, Victoria

Local Institution - 3604, Wodonga, Victoria

Local Institution - 3605, Murdoch, Not set

Local Institution - 3611, Nedlands, Not set

Local Institution - 4052, Fadingerstraße 1, Not set

Local Institution - 4051, Innsbruck, Not set

Local Institution - 4054, Rankweil, Not set

Local Institution - 4053, Wels, Not set

Local Institution - 4160, Brussels, Not set

Local Institution - 4156, Brussels, Not set

Local Institution - 4157, Brussles, Not set

Local Institution - 4154, Charleroi, Not set

Local Institution - 4159, Haine St Paul, Not set

Local Institution - 4158, Leuven, Not set

Local Institution - 4150, Liege, Not set

Local Institution - 4153, Roeselare, Not set

Local Institution - 4151, Yvoir, Not set

Local Institution - 2601, Calgary, Alberta

Local Institution - 2600, Edmonton, Alberta

Local Institution - 2602, Winnipeg, Manitoba

Local Institution - 2611, Saint John, New Brunswick

Local Institution - 2610, Halifax, Nova Scotia

Local Institution - 2606, London, Ontario

Local Institution - 2612, Toronto, Ontario

Local Institution - 2603, Greenfield Park, Quebec

Local Institution - 2605, Montreal, Quebec

Local Institution - 2607, Montreal, Quebec

Local Institution - 4252, Hradec Kralove, Not set

Local Institution - 4250, Praha 10, Not set

Local Institution - 4251, Praha 2, Not set

Local Institution - 4565, Aschaffenburg, Not set

Local Institution - 4550, Berlin, Not set

Local Institution - 4555, Chemnitz, Not set

Local Institution - 4562, Dresden, Not set

Local Institution - 4552, Hamm, Not set

Local Institution - 4553, Heidelberg, Not set

Local Institution - 4560, Jena, Not set

Local Institution - 4563, Koln, Not set

Local Institution - 4554, Mainz, Not set

Local Institution - 4561, Munchen, Not set

Local Institution - 4558, Munster, Not set

Local Institution - 4551, Offenbach, Not set

Local Institution - 4556, Stuttgart, Not set

Local Institution - 4564, Tuebingen, Not set

Local Institution - 4559, Ulm, Not set

Local Institution - 4653, Athens, Not set

Local Institution - 4651, Athens, Not set

Local Institution - 4650, Ioannina, Not set

Local Institution - 4652, Larissa, Not set

Local Institution - 4654, Patras, Not set

Local Institution - 4751, Budapest, Not set

Local Institution - 4754, Budapest, Not set

Local Institution - 4750, Debrecen, Not set

Local Institution - 4753, Gyor, Not set

Local Institution - 4752, Szeged, Not set

Local Institution - 4852, Dublin, Not set

Local Institution - 4850, Dublin, Not set

Local Institution - 4851, Galway, Not set

Local Institution - 4950, Afula, Not set

Local Institution - 4956, Ashkelon, Not set

Local Institution - 4960, Haifa, Not set

Local Institution - 4958, Jerusalem, Not set

Local Institution - 4951, Jerusalem, Not set

Local Institution - 4959, Kfar Saba, Not set

Local Institution - 4954, Nahariya, Not set

Local Institution - 4952, Petah Tikva, Not set

Local Institution - 4957, Tel Aviv, Not set

Local Institution - 4955, Zerifin, Not set

Local Institution - 5067, Ancona, Not set

Local Institution - 5065, Bari, Not set

Local Institution - 5053, Bergamo, Not set

Local Institution - 5070, Bologna, Not set

Local Institution - 5066, Firenze, Not set

Local Institution - 5050, Genova, Not set

Local Institution - 5057, Meldola, Not set

Local Institution - 5075, Milano, Not set

Local Institution - 5069, Milan, Not set

Local Institution - 5052, Monza, Not set

Local Institution - 5062, Napoli, Not set

Local Institution - 5068, Napoli, Not set

Local Institution - 5055, Palermo, Not set

Local Institution - 5063, Ravenna, Not set

Local Institution - 5073, Reggio Nell Emilia (RE), Not set

Local Institution - 5064, Rimini, Not set

Local Institution - 5058, Roma, Not set

Local Institution - 5054, Roma, Not set

Local Institution - 5056, Rome, Not set

Local Institution - 5072, Terni, Not set

Local Institution - 5051, Torino, Not set

Local Institution - 5250, Bialystok, Not set

Local Institution - 5252, Chorzow, Not set

Local Institution - 5254, Gdansk, Not set

Local Institution - 7626, Krakow, Not set

Local Institution - 5258, Lodz, Not set

Local Institution - 5257, Lublin, Not set

Local Institution - 5259, Poznan, Not set

Local Institution - 5255, Szczecin, Not set

Local Institution - 5256, Warszawa, Not set

Local Institution - 5253, Warszawa, Not set

Local Institution - 5260, Warszawa, Not set

Local Institution - 5251, Wroclaw, Not set

Local Institution - 7600, Ponce, Not set

Local Institution - 7602, San Juan, Not set

Local Institution - 5356, Brasov, Not set

Local Institution - 5350, Bucaresti, Not set

Local Institution - 5355, Bucuresti, Not set

Local Institution - 5353, Bucuresti, Not set

Local Institution - 5352, Bucuresti, Not set

Local Institution - 5351, Lasi, Not set

Local Institution - 5453, Samara, Not set

Local Institution - 5450, St. Petersburg, Not set

Local Institution - 5452, St. Petersburg, Not set

Local Institution - 5552, Badalona-barcelona, Not set

Local Institution - 5559, Barcelona, Not set

Local Institution - 5555, Barcelona, Not set

Local Institution - 5561, La Laguna- Tenerife, Not set

Local Institution - 5553, Madrid, Not set

Local Institution - 5551, Madrid, Not set

Local Institution - 5560, Madrid, Not set

Local Institution - 5554, Madrid, Not set

Local Institution - 5558, Pamplona, Not set

Local Institution - 5550, Salamanca, Not set

Local Institution - 5557, San Sebastian, Not set

Local Institution - 5556, Toledo, Not set

Local Institution - 5751, Bern, Not set

Local Institution - 5750, St Gallen, Not set

Local Institution - 5753, Zurich, Not set

Local Institution - 5752, Zurich, Not set

Local Institution - 5853, Izmir, Bornova

Local Institution - 5851, Ankara, Dikimevi

Local Institution - 5854, Izmir, Inciralti

Local Institution - 5856, Gaziantep, Not set

Local Institution - 5951, Belfast, Antrim

Local Institution - 5953, London, Greater London

Local Institution - 5950, London, Not set

Local Institution - 5954, London, Not set

Local Institution - 5952, London, Not set

Local Institution - 5955, London, Not set

Conditions: Multiple Myeloma

Learn More ›

Combination Chemotherapy in Treating Children With Anaplastic Large Cell Lymphoma (ALCL 99)

NCT00006455

Completed

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. It is not yet known which combination chemotherapy regimen is more effective for treating anaplastic large cell lymphoma. PURPOSE: This randomized phase III trial is studying several different regimens of combination chemotherapy to compare how well they work in treating children with anaplastic large cell lymphoma.

Gender:

ALL

Ages:

Between 0 years and 21 years

Trial Updated:

05/24/2022

Locations: St. Anna Children's Hospital, Vienna, Not set +9 locations

Conditions: Lymphoma

Learn More ›

Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma

NCT01239797

Completed

The purpose of the study is to determine whether the addition of Elotuzumab to Lenalidomide/low-dose Dexamethasone will increase the progression free survival (PFS).

Gender:

ALL

Ages:

18 years and above

Trial Updated:

05/05/2022

Locations: Northwest Alabama Cancer Center, Pc, Muscle Shoals, Alabama +215 locations

Northwest Alabama Cancer Center, Pc, Muscle Shoals, Alabama

Acrc/Arizona Clinical Research Center, Inc., Tucson, Arizona

Local Institution, Berkeley, California

Local Institution, Burbank, California

Compassionate Cancer Res Grp, Corona, California

Local Institution, Corona, California

San Diego Pacific Oncology& Hematology Associates, Inc, Encinitas, California

Local Institution, Greenbrae, California

Ucla-Division Of Hematology/Oncology, Los Angeles, California

Medical Oncology Care Associates, Orange, California

Sharp Clinical Oncology Research, San Diego, California

Local Institution, Vallejo, California

Local Institution, Boca Raton, Florida

Cancer Care Centers Of Florida, Brooksville, Florida

Mount Sinai Comprehensive Cancer Center, Miami Beach, Florida

Local Institution, New Port Richey, Florida

Cancer Institute Of Florida, Orlando, Florida

Local Institution, Titusville, Florida

Florida Cancer Specialists, West Palm Beach, Florida

Winship Cancer Institute., Atlanta, Georgia

Georgia Health Science University, Augusta, Georgia

Orchard Healthcare Research Inc., Skokie, Illinois

Local Institution, Indianapolis, Indiana

Local Institution, Mishawaka, Indiana

Local Institution, Iowa City, Iowa

Local Institution, Lexington, Kentucky

Local Institution, Louisville, Kentucky

Pikeville Medical Center, Pikeville, Kentucky

Cancer Center Of Acadiana At Lafayette General, Lafayette, Louisiana

Local Institution, Shreveport, Louisiana

Willis Knighton Cancer Center, Shreveport, Louisiana

Dana Farber Cancer Inst, Boston, Massachusetts

Dana-Farber Cancer Institute, Boston, Massachusetts

Henry Ford Health System, Detroit, Michigan

Capitol Comprehensive Cancer Care Center, Jefferson City, Missouri

Washington University School Of Medicine, Saint Louis, Missouri

Local Institution, Springfield, Missouri

Local Institution, Las Vegas, Nevada

NYU Clinical Cancer Center, New York, New York

Local Institution, New York, New York

Weill Cornell Medical College, New York, New York

Local Institution, Stony Brook, New York

Levine Cancer Institute, Charlotte, North Carolina

Gaston Hematology & Oncology, Gastonia, North Carolina

Local Institution, Bismarck, North Dakota

University Of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma

Local Institution, Tulsa, Oklahoma

Local Institution, Bethlehem, Pennsylvania

Western Pennsylvania Hospital, Pittsburgh, Pennsylvania

Local Institution, Charleston, South Carolina

Local Institution, Greenville, South Carolina

Local Institution, Knoxville, Tennessee

The West Clinic, Memphis, Tennessee

Cancer Specialists Of South Texas, Pa, Corpus Christi, Texas

Ut Southwestern Medical Center, Dallas, Texas

University Of Texas Md Anderson Cancer Ctr, Houston, Texas

Northwest Cancer Center, Houston, Texas

Hematology-Oncology Associates Of Fredricksburg, Inc, Fredericksburg, Virginia

Va Puget Sound Health Care System, Seattle, Washington

Gundersen Clinic, Ltd, La Crosse, Wisconsin

University Of Wisconsin Hospital And Clinics, Madison, Wisconsin

Medical College of Wisconsin, Milwaukee, Wisconsin

Local Institution, Albury, New South Wales

Local Institution, Canberra, New South Wales

Local Institution, South Brisbane, Queensland

Local Institution, Adelaide, South Australia

Local Institution, Malvern, Victoria

Local Institution, Melbourne, Victoria

Local Institution, Nedlands, Western Australia

Local Institution, Murdoch, Not set

Local Institution, Rankweil, Not set

Local Institution, Steyr, Not set

Local Institution, Wels, Not set

Local Institution, Wien, Not set

Local Institution, Antwerpen, Not set

Local Institution, Brussels, Not set

Local Institution, Brussles, Not set

Local Institution, Edegem-antwerp, Not set

Local Institution, Liege, Not set

Local Institution, Yvoir, Not set

Local Institution, Calgary, Alberta

Local Institution, Edmonton, Alberta

Local Institution, Halifax, Nova Scotia

Local Institution, London, Ontario

Local Institution, Toronto, Ontario

Local Institution, Montreal, Quebec

Local Institution, Saskatoon, Saskatchewan

Local Institution, Barrie, Not set

Local Institution, Montreal, Not set

Local Institution, Brno, Not set

Local Institution, Hradec Kralove, Not set

Local Institution, Praha 10, Not set

Local Institution, Praha 2, Not set

Local Institution, Copenhagen, Not set

Local Institution, Odense C, Not set

Local Institution, Vejle, Not set

Local Institution, Blois, Not set

Local Institution, Bordeaux, Not set

Local Institution, Caen, Not set

Local Institution, Clamart Cedex, Not set

Local Institution, La Roche Sur Yon, Not set

Local Institution, La Tronche, Not set

Local Institution, Lille, Not set

Local Institution, Limoges, Not set

Local Institution, Nantes, Not set

Local Institution, Paris 12, Not set

Local Institution, Pierre Benita, Not set

Local Institution, Toulouse, Not set

Local Institution, Tours Cedex, Not set

Local Institution, Vandoeuvre, Not set

Local Institution, Aschaffenburg, Not set

Local Institution, Berlin, Not set

Local Institution, Chemnitz, Not set

Local Institution, Dresden, Not set

Local Institution, Hamburg, Not set

Local Institution, Hamm, Not set

Local Institution, Heidelberg, Not set

Local Institution, Jena, Not set

Local Institution, Kiel, Not set

Local Institution, Koln, Not set

Local Institution, Marburg, Not set

Local Institution, Munchen, Not set

Local Institution, Munster, Not set

Local Institution, Ravensburg, Not set

Local Institution, Tuebingen, Not set

Local Institution, Ulm, Not set

Local Institution, Wurzburg, Not set

Local Institution, Athens, Not set

Local Institution, Ioannina, Not set

Local Institution, Larissa, Not set

Local Institution, Budapest, Not set

Local Institution, Debrecen, Not set

Local Institution, Gyor, Not set

Local Institution, Szeged, Not set

Local Institution, Dublin, Not set

Local Institution, Tullamore, Not set

Local Institution, Afula, Not set

Local Institution, Jerusalem, Not set

Local Institution, Petah Tikva, Not set

Local Institution, Rehovot, Not set

Local Institution, Zerifin, Not set

Local Institution, Ancona, Not set

Local Institution, Bergamo, Not set

Local Institution, Bologna, Not set

Local Institution, Firenze, Not set

Local Institution, Genova, Not set

Local Institution, Meldola, Not set

Local Institution, Milano, Not set

Local Institution, Palermo, Not set

Local Institution, Ravenna, Not set

Local Institution, Rimini, Not set

Local Institution, Roma, Not set

Local Institution, Torino, Not set

Local Institution, Nagoya-shi, Aichi

Local Institution, Maebashi-shi, Gunma

Local Institution, Shibukawa-shi, Gunma

Local Institution, Sapporo-city, Hokkaido

Local Institution, Sendai-shi, Miyagi

Local Institution, Osaka-shi, Osaka

Local Institution, Bunkyo-Ku, Tokyo

Local Institution, Koto-ku, Tokyo

Local Institution, Shibuya-ku, Tokyo

Local Institution, Shinjuuku-ku, Tokyo

Local Institution, Kamogawa, Toyko

Local Institution, Chiba-shi, Not set

Local Institution, Fukuoka, Not set

Local Institution, Kyoto, Not set

Local Institution, Niigata, Not set

Local Institution, Okayama, Not set

Local Institution, Toyohashi-shi, Not set

Local Institution, Bialystok, Not set

Local Institution, Chorzow, Not set

Local Institution, Lublin, Not set

Local Institution, Poznan, Not set

Local Institution, Warszawa, Not set

Local Institution, Wroclaw, Not set

Local Institution, Ponce, Not set

Local Institution, San Juan, Not set

Local Institution, Brasov, Not set

Local Institution, Bucaresti, Not set

Local Institution, Bucuresti, Not set

Local Institution, Badalona-Barcelona, Not set

Local Institution, Madrid, Not set

Local Institution, Murcia, Not set

Local Institution, Salamanca, Not set

Local Institution, Santiago De Comp-coruna, Not set

Local Institution, Toledo, Not set

Local Institution, Bern, Not set

Local Institution, Geneve 14, Not set

Local Institution, Izmir, Bornova

Local Institution, Istanbul, Capa

Local Institution, Ankara, Not set

Local Institution, Izmir, Not set

Local Institution, Leicester, Not set

Local Institution, London, Greater London

Local Institution, Manchester, Greater Manchester

Local Institution, Airdrie, Lancashire

Local Institution, Edinburgh, Midlothian

Local Institution, Nottingham, Nottinghamshire

Local Institution, Sutton, Surrey

Local Institution, Leeds, Not set

Local Institution, London, Not set

Local Institution, Newcastle Upon Tyne, Not set

Conditions: Lymphoma, Multiple Myeloma

Learn More ›